1–7 day access
Supportive oncodermatology expertise
Collaborative care with oncology teams
Support through treatment and survivorship
Cancer treatment often creates urgent dermatologic needs
Modern cancer therapies have improved survival and expanded treatment options, but they also create significant dermatologic side effects — including rash, alopecia, nail changes, itching, dryness, and inflammatory skin reactions. These complications can affect comfort, confidence, and quality of life, while also creating added burden for oncology teams.
Up to 90% of patients may experience skin toxicity during treatment
Dermatologic adverse events are among the most common toxicities of systemic anticancer therapeutics
Managing these toxicities helps reduce the risk of treatment delays or discontinuation.
Management of rash, alopecia, nail changes, pruritus, inflammatory reactions, and therapy-linked skin toxicities
Dermatology care coordinated with oncology teams and integrated into clinical workflows
Add specialty dermatology capacity without new staff, space, or buildout — and your patients stay in your care.
TonoConnect
Refer patients to specialty dermatology, and stay connected to their care
Oncologists and care teams can refer patients to Tono dermatologists for rapid evaluation.
Patients receive priority appointments and return to you with coordinated follow-up and clear recommendations.
Clinical credibility
Specialty expertise your oncology team can rely on
Tono’s dermatologists bring subspecialty focus in the skin, hair, and nail effects of cancer therapy, and help advance the field through active research collaboration with the Department of Dermatology at Mount Sinai. For your patients, that means care grounded in current evidence — and for your team, a dermatology partner that understands the realities of treatment.
“Having dermatology available within days — and coordinated with our team — has meant fewer treatment interruptions for our patients.”
Oncology partner
Tono helps cancer centers access timely dermatology expertise so patients can receive better-supported care throughout treatment.
Dr. Mondana Ghias
Dermatologist and Chief Medical Officer
